Showing all 3 results
The Cancer Antigen 72-4 (CA 72-4) Test is a diagnostic blood test used to detect and monitor gastrointestinal cancers, particularly gastric and colorectal cancer. It measures CA 72-4, a tumor-associated glycoprotein, aiding in early detection, treatment monitoring, and recurrence assessment.
Sample Type : Serum
Methodology : TBA
TAT : 7 Days
Liquid HALLMARK is a comprehensive liquid biopsy test that analyzes circulating tumor DNA (ctDNA) from a simple blood draw to detect and monitor cancer.
Sample Type : Serum
Methodology : Ultra-deep sequencing using Lucence’s proprietary AmpliMARK™ technology
TAT : 8-10 Days
The Oncomine Myeloproliferative Neoplasm (MPN) Panel is a targeted next-generation sequencing (NGS) assay designed for the comprehensive detection of key driver mutations in myeloproliferative neoplasms. It enables the simultaneous analysis of JAK2, CALR, and MPL genes, which are critical for MPN diagnosis and classification. The panel offers high sensitivity, detecting low-frequency variants with as little as 10 ng of input RNA or DNA, making it ideal for limited or degraded samples.